海外の治験の状況「前立腺癌」での検索結果
161件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Study of Immunotherapy to Treat Advanced Prostate Cancer
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Peru, Poland, Puerto Rico, Romania, Russian Federation, Spain, United Kingdom, United States
- 2009-03-12
Not Recruiting
- Prostate Cancer Localization With a Multiparametric MR Approach
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Austria, Belgium, Canada, Germany, Netherlands, Norway, United Kingdom, United States
- 2012-10-11
Not recruiting
- A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care
- Prostate Cancer
- Austria, Belgium, France, Germany, Israel, Italy, Luxembourg, Poland, Portugal, Russian Federation, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom
- 2014-09-08
Not recruiting
- European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Metastatic Castration Resistant Prostate Cancer
- Austria, Belgium, Bulgaria, Czech Republic, Czechia, Denmark, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Portugal, Slovenia, Spain, United Kingdom
- 2015-07-09
Recruiting
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
- Prostate Cancer
- Argentina, Australia, Belgium, Canada, Chile, Czechia, Denmark, Finland, France, Georgia, Germany, Israel, Italy, Korea, Republic of, Moldova, Republic of, New Zealand, Poland, Russian Federation, Slovakia, South Africa, Spain, United Kingdom, United States
- 2016-11-07
Not recruiting
- Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
- Nonmetastatic Castration-Resistant Prostate Cancer;Prostate Cancer;Cancer of the Prostate
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-12-03
Authorised
- A multinational study to evaluate the safety and effectiveness of enzalutamide in patients whose prostate cancer has not metastasized
- Patients With Nonmetastatic Castration Resistant Prostate Cancer br>MedDRA version: 20.0 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Denmark, Finland, France, Germany, Greece, Hong Kong, Italy, Korea, Republic of, Malaysia, Netherlands, New Zealand, Poland, Russian Federation, Serbia, Singapore, Slovakia, Spain, Sweden, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2013-07-10
Recruiting
- Ga-68-PSMA-11 in High-risk Prostate Cancer
- High-risk Prostate Cancer;Prostate Cancer;Prostate Cancer Metastatic;Lymphnode Metastasis
- Austria, Germany, Switzerland
- 2017-10-18
Not Recruiting
- Tasquinimod for metastatic castrate-resistant prostate cancer
- Metastatic Castrate-Resistant Prostate Cancer br>MedDRA version: 17.1 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 17.1 Level: PT Classification code 10062904 Term: Hormone-refractory prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Male diseases of the urinary and reproductive systems [C12]
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Estonia, France, Germany, Greece, Guatemala, Iceland, India, Israel, Italy, Korea, Republic of, Latvia, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Peru, Romania, Slovakia, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2010-10-28
Not recruiting
- Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
- Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male;Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male;Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male;Prostate Neoplasms;Genital Neoplasms, Male;Urogenital Neoplasms;Genital Diseases, Male
- Australia, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Greece, Hong Kong, Hungary, India, Indonesia, Korea, Republic of, Malaysia, Mexico, New Zealand, Poland, Puerto Rico, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, United States
- 2010-10-07
